Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.765 USD | -4.92% | -5.47% | +21.80% |
05-14 | Atea Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-14 | Transcript : Atea Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.80% | 334M | |
+5.50% | 111B | |
+11.71% | 106B | |
-12.40% | 22.24B | |
+0.03% | 21.25B | |
-4.92% | 18.97B | |
-35.21% | 18.52B | |
-11.16% | 16.81B | |
+37.49% | 12.54B | |
-24.76% | 8.09B |
- Stock Market
- Equities
- AVIR Stock
- News Atea Pharmaceuticals, Inc.
- JPMorgan Adjusts Price Target for Atea Pharmaceuticals to $8 From $10, Maintains Neutral Rating